Spinal muscular atrophy: Classification, aetiology, and treatment of spinal deformity in children and adolescents

Current Orthopaedics

Volumn 20, Issue 6, 2006, Pages 430-445

  Tsirikos, Athanasios I ^a   Baker, Alexander D L ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Neuromuscular scoliosis; Paralytic scoliosis; Spinal deformity; Spinal muscular atrophy; Surgical treatment

Indexed keywords

ARTHRODESIS; ARTICLE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; FUNCTIONAL DISEASE; HANDICAPPED CHILD; HUMAN; LIMB WEAKNESS; MALNUTRITION; MORTALITY; MUSCLE WEAKNESS; NERVE INJURY; NEUROPATHIC PAIN; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; SCOLIOSIS; SKELETAL MUSCLE; SPINAL MUSCULAR ATROPHY; SPINE MALFORMATION; SURGICAL TECHNIQUE; TREATMENT INDICATION; WALKING DIFFICULTY;

EID: 33846341714     PISSN: 02680890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cuor.2006.09.006     Document Type: Article

References (80)

1. Von Gontard A., Zerres K., Backes M., et al. Intelligence and cognitive function in children and adolescents with spinal muscular atrophy. Neuromusc Dis 12 2 (2002) 130-136
2. Dubowitz V. Infantile muscular atrophy: a prospective study with particular reference to a slowly progressive variety. Brain 87 (1964) 707-718
3. Moosa A., and Dubowitz V. Spinal muscular atrophy in childhood: two clues to clinical diagnosis. Arch Dis Child 48 (1973) 386-388
4. Munsat T.L. Workshop report, International SMA collaboration. Neuromusc Dis 1 (1991) 81
5. Hoffman J. Ueber chronischespinale Muskelatrophie im Kindersalter, auf familiarer Basis. Dutsch Z Nervenheulkd 3 (1893) 427
6. Werdnig G. Die Fruhinfantile progressive spinale Amyotrophie. Arch Psychiatr Nervenkr 26 (1894) 706
7. Kugelberg E., and Welander L. Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. Arch Neurol Psychiary 75 (1956) 500
8. Pearn J. Classification of Spinal Muscular Atrophies. Lancet 1 8174 (1980) 912-922
9. Evans G.A., Drennan J.C., and Russman B.S. Funtional classification and orthopaedic management of Spinal Muscular Atrophy. JBJ S (Br) 63 (1981) 516
10. Dubowitz V. Muscle disorders in childhood (1978), W.B. Saunders, Philadelphia, PA
11. Pearn J. The gene frequency of acute Werdnig-Hoffmann disease (SMA Type I). A total population survey in North East England. J Med Genet 10 (1973) 260-265
12. Munsat T. The spinal muscular atrophies. Current Neurol 3 14 (1994) 55-71
13. Winsor E.J., Murphey E.G., Thomson M.W., et al. Genetics of childhood spinal muscular atrophy. J Med Genet 8 (1971) 143-148
14. Ignatius J., and Donner M. Epidemiology of childhood spinal muscular atrophy (in Finnish). In: Lang H. (Ed). Lihastautien Kehittyva Tutkimus Ja Hoito (1989), Kiasma, Turku
15. Czeizel A., and Hamula J. A Hungarian study on Werdnig-Hoffmann disease. J Med Genet 26 (1989) 761-763
16. Tangsrud S.-E., and Halvorsen S. Child neuromuscular disease in Southern Norway. Prevalence, age, and distribution of diagnosis with special reference to non-Duchenne muscular dystrophy. Clin Genet 34 (1988) 145-152
17. Pearn J. Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 15 (1978) 409-413
18. Emery A.E.H. Population frequencies of inherited neuromuscular diseases-A world survey. Neuromusc Disorders 1 1 (1991) 19-29
19. Al-Rajeh S., et al. Werdnig-Hoffmann disease (spinal muscular atrophy type I): a clinical study of 25 Saudi Nationals in Al-Khobar. Ann Saudi Med 12 (1992) 67-71
20. Fried K., and Mundel G. High incidence of spinal muscular atrophy type I (Werdnig-Hoffmann disease) in the Karaite community in Israel. Clin Genet 12 4 (1977) 250-251
21. Brzustowicz L.M., Lehner T., Caxtilla L.H., et al. Genetic mapping of childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 344 (1990) 540-541
22. Lefevre S., Burglen L., Reboullet S., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80 (1995) 155-165
23. Monani U.R. Spinal Muscular Atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 48 (2005) 885-896
24. Coovert D.D., Le T.T., McAndrew P.E., et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6 8 (1997) 1205-1214
25. Thieffry A., Arthus M., and Bargeton E. Quarante cas de maladie de Werdnig-Hoffman avec onje examens anatomiques. Rev Neurol 93 (1955) 621-644
26. Carpenter S., Karpati G., Rothman S., et al. Pathological involvement of primary sensory beurones in Werdnig-Hoffmann disease. Acta Neuropath 42 (1978) 91-97
27. Sambuughin N., Sivakumar K., Selenge B., et al. Autosomal dominant distal spinal muscular atropy V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15. J Neurol Sci 161 (1998) 23-28
28. Zellweger H., Simpson J., McCormick W.F., et al. Spinal Muscular Atrophy with autosomal dominant inheritance. Neurology 22 (1972) 957
29. Van der Vleuten A.J., van Ravenswaaij-Arts C.M., Frijns C.J., et al. Localisation of the gene for a dominant congenital spinal muscular atrophy predominantly affecting the lower limbs to chromosome 12q23-q24. Eur J Hum Genet 6 (1998) 376-382
30. Greenberg F., Feuolia K.R., Hetmancik J.F., et al. X-linked infantile spinal muscular atrophy. Am J Dis Child 142 (1988) 217
31. La Spada A.R., Wilson E.M., Lubahn D.B., et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 (1991) 77-79
32. Kobayashi H., Baumbach L., Matise T.C., et al. A gene for a severe lethal form of X-linked athrogryposis (X-linked infantile spinal muscular atrophy) maps to human chromosome Xp11.3-q11.2. Hum Mol Genet 4 (1995) 1213-1216
33. Viollet L., Barois A., Rebeiz J.G., et al. Mapping of an autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13. Ann Neurol 51 (2002) 585-592
34. Grohmann K., Schuelke M., Diers A., et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 casuses spinal muscular atrophy with respiratory distress type 1. Nat Genet 29 (2001) 75-77
35. Russman B.S., Iannacone S.T., Buncher C.R., et al. Spinal muscular atrophy: new thoughts on pathogenesis and classification schema. J Child Neurol 7 4 (1992) 347-353
36. Iannaccone S.T., Russman B.S., Browne R.H., et al. Prospective analysis of strength in spinal muscular atrophy. J Child Neurol 15 2 (2000) 97-101
37. Schwentker E.P., and Gibson D.A. The orthopaedic aspects of spinal muscular atrophy. JBJS (Am) 58 1 (1976) 32-37
38. Buchthal F., and Olsen P.Z. Electromyography and muscle biopsy in infantile spinal muscular atrophy. Brain 93 (1970) 15-30
39. Drennan J.C. Skeletal deformities in spinal muscular atrophy. Clin Orthop 133 Abst (1978) 266-267
40. Renault F., Raimbault J., Praud J.P., et al. Etude electromyographique de 50 cas de maladie de Werdnig-Hoffman. Rev Electroencephalogr Neurophysiol Clin 13 (1983) 301-305
41. Van Der Steege G., Grootscholten P.M., Van Der Vlies P., et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 345 (1995) 985-986
42. Liu G.C., Jong Y.J., Chiang C.H., et al. Spinal muscular atrophy: MR evaluation. Pediatr Rad 22 8 (1992) 584-586
43. Shapiro F., and Specht L. Current concepts review. The diagnosis and orthopaedic treatment of childhood Spinal Muscular Atrophy, Peripheral Neuropathy, Friedreich Ataxia, and Athrogryposis. JBJS (Am) 75 11 (1993) 1699-1714
44. Thompson C.E., and Larsen L.J. Recurrent hip dislocation in intermediate spinal atrophy. J Ped Orthop 10 (1990) 638-641
45. Sporer S., and Smith B. Hip dislocation in patients with Spinal Muscular Atrophy. J Ped Orthop 23 1 (2003) 10-14
46. Granata C., Merlini L., Magni E., et al. Spinal Muscular Atrophy: natural history and orthopaedic treatment of scoliosis. Spine 14 7 (1988) 760-762
47. Brown J.C., Zeller J.L., Swank S.M., et al. Surgical and functional results of spine fusion in Spinal Muscular Atrophy. Spine 14 7 (1989) 763-770
48. Hensinger R.N., and MacEwan G.D. Spinal deformity associated with hereditable neurological conditions: Spinal Muscular Atrophy, Freidreich's Ataxia, familial dysautonomia, and Charcot-Marie-Tooth Disease. JBJS (Am) 58 1 (1976) 13-24
49. Aprin H., Bowen R., MacEwen G.D., et al. Spine fusion in patients with Spinal Muscular Atrophy. JBJS (Am) 64 8 (1982) 1179-1187
50. Rodillo E., Marini M.L., Heckmatt J.Z., et al. Scoliosis in Spinal Muscular Atrophy: review of 63 cases. Jr Child Neurol 4 2 (1989) 118-123
51. Phillips D.P., Roye D.P., Farcy J.C., et al. Surgical treatment of scoliosis in a Spinal Muscular Atrophy population. Spine 15 9 (1990) 942-945
52. Benady S.G. Spinal muscular atrophy in childhood: review of 50 cases. Dev Med Child Neurol 20 (1978) 746-757
53. Merlini L., Granata C., Bonfiglioli S., Marini M., Cervellati S., and Savini R. Scoliosis in Spinal Muscular Atrophy: Natural history and management. Dev Med Child Neurol 31 (1989) 501-508
54. Riddick M.F., Winter R.B., and Luter L.D. Spinal deformities in patients with spinal muscular atrophy: a review of 36 patients. Spine 7 5 (1982) 476-483
55. Bradford D.S., and Hu S.S. Neuromuscular spinal deformity. Moe's textbook of scoliosis and other spinal deformities. 3rd ed (1978), W.B. Saunders Company, Philadelphia
56. Bach J.R., and Bianchi C. Prevention of pectus excavatum for children with Spinal Muscular Atrophy Type1. Am J Physic Med Rehab (2003) 815-819
57. Britcha J., Hofmann Y., Hahnen E., et al. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 12 19 (2003) 2481-2489
58. Chang J.G., Hsieh-Li H.M., Jong Y.J., et al. Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98 (2001) 9808-9813
59. Brahe C., Vitali T., Tiziano F.D., et al. Phenyl butyrate increases the SMN gene expression in spinal muscular atrophy patients. Eur J Hum Genet 13 (2005) 256-259
60. Wolstencroft EC, Mattis V, Bajer AA. A non-sequence-specific requirement for SMN protein activity: the role of aminogycosides in inducing elevated SMN protein levels. Hum Mol Genet; 14:1199-1210.
61. Andreassi C., Jarecki J., Zhoe J., et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 10 24 (2001) 2841-2849
62. Savini R, Cervellati S, Granata C, et al. La Scoliosi nelle atrofie muscolari prossimaii infantile. In: Grupo Italiano di studio della scoliosis, ed. Progressi in patalogia vertebrate. 1980 Bologna: Editore Aulo Gaggi.
63. Sharpio F., and Bresnan M.J. Orthopaedic management of childhood neuromuscular disease, 1: Spinal Muscular Atrophy. JBJS (Am) 64 (1982) 785-789
64. Dorr J.R., Brown J.C., and Perry J. Results of posterior spinal fusion in patients with spinal muscular atrophy. A review of 25 cases. JBJS (Am) 55 (1973) 436-437
65. Kinali M., Banks L.M., and Mercuri E. Bone mineral density in a paediatric Spinal Muscular Atrophy population. Neuropaediatrics 35 (2004) 325-328
66. Freeman BL, Scoliosis and Kyphosis. Campbell's Operative Orthopaedics. 10th ed., vol. 38. Mosby Philadelphia 2003, p. 1855-7.
67. Padman R., and McNamara R. Postoperative pulmonary complications in children with neuromuscular scoliosis who underwent posterior spinal fusion. Delaware Med J 62 5 (1990) 999-1003
68. Frownfelter D.L. Chest physical therapy and pulmonary rehabilitation. An interdisciplinary approach. 2nd ed (1987), Year Book, Chicago
69. Lonstein J.E., and Renshaw T.S. Neuromuscular spine deformities. American Academy of Orthopaedic Surgeons: instructional course lectures 36 (1987), Mosby St. Louis
70. Leighton S. Nutritional issues associated with spinal muscular atrophy. Nutrition and Dietetics 60 (2003) 92-96
71. Cole J., Murray D.J., Snider R.J., et al. Aprotinin reduces blood loss during spinal surgery in children. Spine 21 (2003) 2482-2485
72. Dayher Y.H., Lonstein J.E., Winter R.B., et al. Spinal deformities in patients with Freidreich ataxia: a review of 19 patients. J Ped Orthop 5 (1985) 553-557
73. Luque E.R. Paralytic scoliosis in growing children. Clin Orthop 163 (1982) 202-209
74. Gau Y.L., Lonstein J.E., Winter R.B., et al. Luque-Galveston procedure for correction and stabilization of neuromuscular scoliosis and pelvic obliquity: a review of 68 patients. J Spinal Disord 4 4 (1991) 399-410
75. Sussman M.D., Little D., Maxwell A.R., et al. Posterior instrumentation and fusion of the thoracolumbar spine for treatment of neuromuscular scoliosis. J Ped Orthop 16 3 (1996) 304-313
76. Allen B.L., and Ferguson R.L. The Galveston technique for L-rod instrumentation of the scoliotic spine. Spine 7 (1982) 276-284
77. Kepes E.R., Martinez L.R., Andrews I., et al. Anaesthetic problems in hereditary muscular abnormalities. NY State J Med 72 (1972) 1051
78. Linston M., Bresnan M., Eraklis A., et al. Acute gastric volvulus following Harrington rod instrumentation in a patient with Werdnig-Hoffman disease. Spine 6 (1981) 522-523
79. Piasecki J.O., Mahinpour S., and Levine D.B. Long-term follow up of spinal fusion in spinal muscular atrophy. Clin Orthop 207 (1986) 44-54
80. Furumasu J., Swank S.M., Brown J.C., et al. Functional activities of spinal muscular atrophy patients after spinal fusion. Spine 14 (1989) 771-775